Effect of Norepinephrine-Induced Mean Arterial Pressure Changes on Peripheral Perfusion in Septic Shock Patients After Early Resuscitation

0
0
0

Effect of Norepinephrine-Induced Mean Arterial Pressure Changes on Peripheral Perfusion in Septic Shock Patients After Early Resuscitation

Septic shock is a life-threatening condition where infection triggers widespread inflammation, dropping blood pressure so low that organs can’t get enough oxygen. For doctors, the challenge isn’t just raising blood pressure—it’s making sure that pressure actually delivers blood to tissues. A key tool here is mean arterial pressure (MAP), the average pressure in arteries that drives blood flow to organs. But how do you know if your MAP target is working?

Enter the peripheral perfusion index (PI): a simple, real-time number from standard pulse oximeters that measures blood flow to your fingers (calculated as the ratio of pulsatile [beating] to non-pulsatile blood flow). PI is cheap, non-invasive, and gives instant feedback on whether blood is reaching peripheral tissues—something standard blood pressure monitors can’t do.

A 2020 study from researchers at Peking Union Medical College Hospital set out to answer a critical question: When you adjust MAP using norepinephrine (NE)—the first-line drug for septic shock—how does PI respond? Their findings, published in the Chinese Medical Journal, offer new insights into personalized care for septic shock patients.

What the Study Did

The team enrolled 20 adult septic shock patients who had completed early resuscitation (stabilized with fluids, MAP ≥65 mmHg, and on NE to maintain pressure). All patients had a history of “usual” MAP (from medical records), and the researchers titrated NE to test three levels:

  • Usual MAP minus 10 mmHg
  • Usual MAP (baseline)
  • Usual MAP plus 10 mmHg

At each level, they measured MAP, heart rate, cardiac output (CO—the amount of blood the heart pumps per minute), central venous pressure (CVP—pressure in the heart’s main vein), and PI (from a finger pulse oximeter). Patients stabilized for 10 minutes at each pressure before data was recorded.

Key Findings: Variability Is the Rule

The results were clear: There’s no “one-size-fits-all” MAP for good tissue perfusion.

  1. NE raised MAP—but PI didn’t follow a pattern: As NE doses increased, MAP and CVP went up predictably (e.g., from 82 mmHg to 107 mmHg). But PI—their measure of peripheral blood flow—didn’t change consistently. Some patients had better PI at lower MAP; others needed higher pressure.
  2. Most patients didn’t peak at “usual” MAP: Only 3 of 20 patients had their highest PI at their baseline “usual” MAP. Seven did better at 10 mmHg below usual, and 10 did better at 10 mmHg above.
  3. PI didn’t depend on cardiac output: Surprisingly, changes in PI weren’t linked to changes in CO (the heart’s pumping power). This means even if the heart was pumping more blood, it didn’t always reach the fingers—a sign of “hemodynamic incoherence,” where global (whole-body) blood flow doesn’t match local (tissue) flow.

Why This Matters for Septic Shock Care

Septic shock treatment has long focused on hitting a MAP target (usually 65 mmHg) early on. But after stabilization, guidelines say to individualize pressure targets—especially for patients with a history of high blood pressure. This study adds weight to that idea:

  • PI is a practical tool for personalized care: PI comes from standard hospital monitors (no extra equipment needed) and gives real-time feedback. For clinicians, this means they can adjust NE doses while watching PI to see if blood flow to tissues improves—no waiting for lab results or organ damage signs.
  • “Usual” MAP isn’t always best: The fact that most patients had their best PI outside their usual MAP suggests relying on medical history alone isn’t enough. PI helps bridge the gap between “what the numbers say” and “what the tissues need.”
  • Global vs. local flow matters: The lack of a link between CO and PI is a reminder that septic shock damages blood vessels in ways that make whole-body measurements less reliable. PI focuses on the end result—whether blood is actually reaching the fingers—rather than just the heart’s output.

Limitations to Consider

Like all research, this study has caveats:

  • Small sample size: Only 20 patients were included (single-center, short timeframe). Larger studies are needed to confirm results.
  • Finger perfusion isn’t everything: PI measures blood flow to the fingers, not vital organs like the kidneys or brain. But previous research shows low PI is a strong predictor of poor outcomes in critically ill patients—so it’s still a useful “proxy” for tissue health.
  • No long-term outcomes: The study didn’t track mortality or organ function over time. Future work should test whether PI-guided MAP targets actually improve survival.

What’s Next?

For septic shock patients, the goal isn’t just “normal” blood pressure—it’s effective blood pressure. This study suggests PI could be a game-changer for clinicians looking to tailor care to each patient. Imagine a world where, instead of guessing if a higher NE dose is helping, you just glance at a monitor to see if PI goes up—proof that blood is reaching the tissues that need it.

As the Surviving Sepsis Campaign notes, septic shock management is moving away from “one-size-fits-all” targets toward tissue perfusion-based care. The peripheral perfusion index is a simple, accessible way to make that shift a reality.

Citation: He HW, Liu WL, Zhou X, Long Y, Liu DW. Effect of mean arterial pressure change by norepinephrine on peripheral perfusion index in septic shock patients after early resuscitation. Chinese Medical Journal. 2020;133(18):2146–2152.

doi: doi.org/10.1097/CM9.0000000000001017

Was this helpful?

0 / 0